职称：副教授

研究方向：抗肿瘤药物

联系方式：juwang@hebau.edu.cn

主讲课程：人体解剖生理学

教育背景：

2016-2020，南开大学理学博士；

2017-2020，美国维克森林大学医学中心访问学者。

主持课题:河北农业大学人才引进专项

代表性学术成果

近期论文：

1. J. Wang*, D. Li, W. Shen, W. Sun, R. Gao, P. Jiang, L. Wang, Y. Liu, Y. Chen, W.Zhou, R. Wang, R. Xiang, D. Stupack, N. Luo, RHAMM inhibits cell migration via the AKT/GSK3beta/Snail axis in luminal A subtype breast cancer, Anat Rec (Hoboken).(2019) WOS:000501715100001;

[2] J. Wang*, G. Wang*, D. Cheng, S. Huang, A. Chang, X. Tan, Q. Wang, S. Zhao, D. Wu, S. Yang, R. Xiang, P. Sun, Her2 promotes early dissemination of breast cancer by suppressing the p38-MK2-Hsp27 pathway that is targetble by Wip1 inhibition. (Oncogene). (2020) WOS:000563171800001;

[3] G. Wang*, J. Wang*, A. Chang, D. Cheng, S. Huang, D. Wu, S. Sherona, S. Yang, H. Lin, H. Lo. R. Xiang, P. Sun, Her2 promotes early dissemination of breast cancer by suppressing the p38 pathway through Skp2-mediated proteasomal degradation of Tpl2. (Oncogene). (2020) WOS:000573446900005;

[4] Antao Chang*，Liang Liu*，Justin M Ashby，Dan Wu，Yanan Chen，Stacey S O'Neill，Shan Huang，Juan Wang，Guanwen Wang，Dongmei Cheng，Xiangming Tan，W Jeffrey Petty，Boris C Pasche Rong Xiang，Wei Zhang，Peiqing Sun，Recruitment of KMT2C/MLL3 to DNA damage sites mediates DNA damage responses and regulates PARP inhibitor sensitivity in cancer.(Cancer Research) (2021);

[5] W. Shen*, A. Chang, J. Wang, W. Zhou, R. Gao, J. Li, Y. Xu, X. Luo, R. Xiang, N. Luo, D.G. Stupack, TIFA, an inflammatory signaling adaptor, is tumor suppressive for liver cancer. (2015) Oncogenesis 2015 Oct 26;4(10).

注：*代表第一作者